When conducting a clinical investigation, meeting regulatory requirements is predicated on factors such as the quality of ...

Beta CEO Marcel Botha talks about the FDA’s plans for medical shortage notifications and how Trump’s policies may impact US ...

Guilford-based Hyperfine, which had 131 workers as of February 2024, is laying off 14% percent of its workforce.

Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Peter Oppenheimer, the chief of global equity strategy and the head of macro research for Goldman Sachs in Europe, opined ...

Security integrators are many businesses’ first contacts when it comes to ensuring their data is safeguarded within measures set by complex compliance laws.

Unique dense breast tissue focus to drive expedited recruitment rates; modular clinical study design reduces time to PMA ...

Agencies have until April 20 to recommend federal employee positions to be converted into the new “Policy/Career” ...

Farmers face mounting pressure to optimize resources, reduce costs, and boost productivity. Enter farm management software—a ...

Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics ...